|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
|
Resverlogix Corp.
|
Jun 14, 2023 03:46PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 03:47PM
|
|
Re: Rampant bull on the science, but some concerns over the money end linger.
|
1
|
Zenith Epigenetics
|
Jun 18, 2020 07:12PM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 09, 2021 07:39PM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 10, 2021 07:19PM
|
|
Re: Question
|
3
|
Resverlogix Corp.
|
Feb 24, 2021 07:11PM
|
|
Re: Question
|
7
|
Resverlogix Corp.
|
Feb 24, 2021 07:45PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 22, 2022 08:53PM
|
|
Re: Providence Therapeutics
|
4
|
Resverlogix Corp.
|
Sep 14, 2021 12:41PM
|
|
Re: Prof.Kausic Ray
|
3
|
Resverlogix Corp.
|
Jul 12, 2020 05:24PM
|
|
Re: Presentation
|
3
|
Resverlogix Corp.
|
Sep 11, 2020 08:54PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
|
Resverlogix Corp.
|
Nov 30, 2022 12:26PM
|
|
Re: Ownership Update
|
|
Resverlogix Corp.
|
Feb 27, 2023 12:19PM
|
|
Re: Option #2
|
1
|
Resverlogix Corp.
|
Sep 11, 2020 08:24PM
|
|
Re: One week later....
|
3
|
Resverlogix Corp.
|
May 21, 2021 10:57PM
|
|
Re: New Share Price Contest update to Oct 27th
|
2
|
Resverlogix Corp.
|
Oct 28, 2019 12:33AM
|
|
Re: New MD&A posted
|
1
|
Resverlogix Corp.
|
Dec 18, 2019 03:43PM
|
|
Re: New article on Apabetalone
|
2
|
Resverlogix Corp.
|
Oct 16, 2017 12:49PM
|
|
Re: My Rant - Limited attendance AGM, one way communication, vetted questions
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 09:07AM
|
|
Re: My Rant - Limited attendance AGM, one way communication, vetted questions
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 11:21AM
|
